Cardiovascular 1. The medical diagnosis of John relates to acute Ml. Myocardial infarctions happen after a suffering from a long-term ischemia leading to significant damages to the heart muscles.
2. Myocardial infarctions can be divided into non-ST elevation Ml (non-STEMl) and ST-elevation Ml (STEMl). A STEMl is caused by the sudden blocking of the coronary artery. An individual suffering from STEMl needs immediate medical attention including immediate cardiac catheterization and stent placement. The recommendable medical intervention is the use of the percutaneous coronary intervention (PCl), which is more effective than clot-busting drugs in treating STEMl (Yusuf, et al., 2016). ln contrast, non-STEMl is the less damaging blockage of the artery that is not severe to the health of the patients.
3. The pathophysiological findings relating to an Ml includes experiencing severe pain than the normal angina pain. Experiencing nausea and becoming pale also shows the adverse concerns for suffering from an acute Ml.
4. Silent myocardial ischemia is a critical indicator of the occurrence of coronary heart condition that occurs to the patients. ln contrast, angina refers to the cardinal sign of myocardial ischemia and coronary heart condition. Myocardial ischemia triggers the occurrence of angina and it involves the limitation of the overall blood flow into the heart muscles.
5. Some of the risk indicators associated with Sudden Cardiac Death (SCD) including the following: historical heart attack, coronary artery conditions, and family medical history of suffering from cardiovascular condition. A person who has suffered from past heart attacks faces a high risk of suffering from sudden cardiac arrest (Townsend, et al., 2016). Coronary artery condition also the possibility of SCD. Medical family history also plays into causing sudden cardiac arrest.
6. The NP should be aware of the potential post-Ml complications while taking care for John including the disturbance rate, heart failure, ventricular defect, ruptured papillary muscles, and potential cardiac rupture.
References Townsend, N., Wilson, L., Bhatnagar, P., Wickramasinghe, K., Rayner, M., & Nichols, M. (2016). Cardiovascular disease in Europe: epidemiological update 2016. European Heart Journal, 37(42), 3232-3245. Yusuf, S., Bosch, J., Dagenais, G., Zhu, J., Xavier, D., Liu, L., … & Avezum, A. (2016). Cholesterol lowering in intermediate-risk persons without cardiovascular disease. New England Journal of Medicine, 374(21), 2021-2031.

Published by
Thesis
View all posts